Unlocking the Power of RWE in Oncology: Insights from ASCO 2018

Listen to Alastair MacDonald, Syneos Health's Vice President and Head of Client Engagement in Real World and Late Phase, share key insights and learnings from American Society of Clinical Oncology (ASCO) 2018. He discusses the continuing journey in personalized medicine; particularly, in the immuno-oncology space. A growing appetite in understanding how drugs are being used in real life has grown among clinicians working in the field, and Alastair explores the factors behind this trend.